Emergent BioSolutions Inc. (EBS) today announced that it has completed a new five-year, $200 million syndicated senior secured credit facility. This new facility replaces and represents an increase from the Company’s prior $100 million facility, which was scheduled to expire in December 2018. The new facility enhances the Company’s financial flexibility, providing increased capacity to drive growth through strategic acquisitions along with working capital as needed.
{iframe}https://seekingalpha.com/pr/16955921-emergent-biosolutions-announces-closing-new-200-million-senior-secured-credit-facility{/iframe}